Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F66C3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,259
Award facts
- Contract value 100% obligated
- $10,258.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,258.77 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 20, 2026, for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside award leverages the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally. The product will be delivered to the company's Conshohocken, Pennsylvania facility, with an ultimate completion date of January 21, 2026. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that regularly fulfills federal medical procurement requirements through competitive procurement with the Defense Logistics Agency.
This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. Eliquis, an anticoagulant medication, is a critical therapeutic product used across military treatment facilities and veteran healthcare systems. The award demonstrates Amerisourcebergen's continued capability to meet federal medical supply needs through its established IDC vehicle, which enables efficient and responsive delivery of essential pharmaceuticals across multiple therapeutic domains to support Department of Defense healthcare missions worldwide.
Quick answers
Who was awarded contract SPE2DR26F66C3?
SPE2DR26F66C3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F66C3 worth?
The government has obligated $10,259 on SPE2DR26F66C3.
Is contract SPE2DR26F66C3 an order under another contract?
Yes. SPE2DR26F66C3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66C3 competed?
The extent of competition for SPE2DR26F66C3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award